Integrated Care News by CFHA
MAY 8, 2025
Vaccine hesitancy is the delay in accepting or refusing vaccination despite the availability of vaccination services. It falls on a spectrum of vaccine attitudes and intentions, from those who recognize the importance of vaccines and accept all vaccines on one end of the spectrum to those who refuse all vaccines.
Minnesota Academy of Family Physicians
JUNE 20, 2025
AAFP Denounces Changes to ACIP and Vaccine Recommendations The Minnesota Academy of Family Physicians (MAFP) stands with the American Academy of Family Physicians (AAFP) in denouncing the recent decisions made by Health and Human Services (HHS) Secretary, Robert F. Kennedy, Jr. Call to Action The MAFP urges members to speak out.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Medical Xpress
APRIL 7, 2023
After helping to develop and test new mRNA technologies for COVID-19 vaccines, University of Maryland School of Medicine (UMSOM) researchers and scientists are turning their attention to utilizing this innovative technology to ward off other infectious diseases like malaria and influenza.
Annals of Family Medicine
NOVEMBER 20, 2024
Context: The human papillomavirus (HPV) vaccine is recommended starting at age 9 to reduce risk of HPV linked squamous cell cancers, yet recent data shows that only 58.6% have been vaccinated by age 17. Secondary acceptance is agreeing to a vaccine subsequent to declining in a previous encounter. Child (e.g.,
Annals of Family Medicine
NOVEMBER 20, 2024
HPV vaccination is recommended for all children starting at age nine years, and it is most effective before HPV exposure. Some research has found lower HPV vaccine uptake in Latino patients and others have demonstrated higher uptake by Latino subgroups. 2 doses compared to non-Hispanic white adolescents.
The Clinical Problem Solvers
MAY 2, 2022
Dr. Valtis is a 4th year Med-Peds Resident at Brigham & Women’s Hospital and Boston Children’s Hospital, and his research focuses on race and the utilization of security responses in the inpatient hospital setting. Yannis Valtis, Ebi Okah, and Carine Davila, about research in their respective fields. His team found that 1.5%
Physician's Weekly
JUNE 19, 2025
Most patients (71.0%) had received the current season’s RSV vaccine. While RSV types A and B showed no significant differences in clinical outcomes, chronic obstructive pulmonary disease and chronic kidney disease emerged as factors associated with disease severity, alongside frailty,” the researchers wrote. Additionally, 63.8%
Expert insights. Personalized for you.
130 
Let's personalize your content